Adherence to pan‐genotypic glecaprevir/pibrentasvir and efficacy in HCV‐infected patients: A pooled analysis of clinical trials

BACKGROUND & AIMS: Adequate adherence to hepatitis C virus (HCV) treatment is believed to be a key component of treatment success because non‐adherence can potentially result in treatment failure and the emergence of resistant viral variants. This analysis assessed factors associated with non‐ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Ashley, Welzel, Tania M., Conway, Brian, Negro, Francesco, Bräu, Norbert, Grebely, Jason, Puoti, Massimo, Aghemo, Alessio, Kleine, Henning, Pugatch, David, Mensa, Federico J., Chen, Yaozhu J., Lei, Yang, Lawitz, Eric, Asselah, Tarik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Viral Hepatitis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187170/
https://www.ncbi.nlm.nih.gov/pubmed/31568620
http://dx.doi.org/10.1111/liv.14266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187170/
https://www.ncbi.nlm.nih.gov/pubmed/31568620
http://dx.doi.org/10.1111/liv.14266

Ejemplares similares